Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
AMPE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 3.71%45.020.0%$295.73m
GWPHGW Pharmaceuticals Plc -0.10%214.726.1%$259.81m
VRXValeant Pharmaceuticals International, Inc. 0.36%33.0914.1%$194.71m
BHCBausch Health Cos., Inc. 0.36%33.090.0%$177.02m
HZNPHorizon Therapeutics Plc -2.12%86.775.5%$175.60m
JAZZJazz Pharmaceuticals Plc -2.03%161.412.3%$148.59m
ICLRICON plc 0.22%180.224.2%$134.70m
CTLTCatalent, Inc. -2.78%101.642.1%$101.71m
PRGOPerrigo Co. Plc 1.78%41.776.9%$85.75m
ARGXargenx SE 2.09%295.790.0%$59.45m
TNXPTonix Pharmaceuticals Holding Corp. 0.00%1.020.2%$52.97m
UTHRUnited Therapeutics Corp. -2.59%160.0914.1%$47.98m
AMRNAmarin Corp. Plc -3.34%5.791.5%$36.94m
ZYNEZynerba Pharmaceuticals, Inc. -0.24%4.146.0%$36.93m
SAGESAGE Therapeutics, Inc. -2.70%74.907.6%$35.44m

Company Profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.